These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30107868)

  • 21. Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Craig T; Magerl M; Levy DS; Reshef A; Lumry WR; Martinez-Saguer I; Jacobs JS; Yang WH; Ritchie B; Aygören-Pürsün E; Keith PK; Busse P; Feuersenger H; Pawaskar D; Jacobs I; Pragst I; Doyle MK
    Lancet; 2022 Mar; 399(10328):945-955. PubMed ID: 35219377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
    Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
    J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
    Riedl MA; Bygum A; Lumry W; Magerl M; Bernstein JA; Busse P; Craig T; Frank MM; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
    J Allergy Clin Immunol Pract; 2016; 4(5):963-71. PubMed ID: 27286778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry.
    Busse P; Bygum A; Edelman J; Lumry W; Machnig T; Martinez-Saguer I; Rojavin M
    J Allergy Clin Immunol Pract; 2015; 3(2):213-9. PubMed ID: 25609333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.
    Farkas H; Kőhalmi KV; Veszeli N; Zotter Z; Várnai K; Varga L
    Allergy Asthma Proc; 2016; 37(2):164-70. PubMed ID: 26802388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1-esterase inhibitor (Cinryze
    Gupta R; Balduzzi J; Davis-Lorton M
    Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema.
    Aygören-Pürsün E; Soteres DF; Nieto-Martinez SA; Christensen J; Jacobson KW; Moldovan D; Van Leerberghe A; Tang Y; Lu P; Vardi M; Schranz J; Martinez-Saguer I
    Pediatr Allergy Immunol; 2019 Aug; 30(5):553-561. PubMed ID: 30968444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
    Bork K; Craig TJ; Bernstein JA; Feuersenger H; Machnig T; Staubach P
    Allergy Asthma Proc; 2015; 36(3):218-24. PubMed ID: 25803207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
    Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
    Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
    Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M
    Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy.
    Lumry W; Templeton T; Omert L; Levy D
    J Infus Nurs; 2020; 43(3):134-145. PubMed ID: 32287168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of weight on the efficacy and safety of C1 esterase inhibitor concentrate for the treatment of acute hereditary angioedema.
    Bernstein JA; Machnig T; Keinecke HO; Whelan GJ; Craig TJ
    Clin Ther; 2014 Apr; 36(4):518-25. PubMed ID: 24661784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.